Clinical Trials Logo

Atheromatous clinical trials

View clinical trials related to Atheromatous.

Filter by:
  • None
  • Page 1

NCT ID: NCT06226844 Not yet recruiting - Lower Limb Ischemia Clinical Trials

Can the BeatMove Device Help Patients With Obliterative Arterial Disease of the Lower Limbs?

LEGS GO
Start date: June 1, 2024
Phase:
Study type: Observational

Vascular rehabilitation for arteriopathy of the lower limbs remains little known in France, despite its good results. There are very few rehabilitation centres, and they are overcrowded and expensive. Outpatient walking rehabilitation is under-used, despite recommendations (4). One of the difficulties is getting patients to adhere to the treatment sufficiently and for a long time. According to the Fédération Française de Musicothérapie (FFM), this is a care practice based on sound or musical mediation with the aim of supporting, accompanying or re-educating a patient. Music is used as a means of expression, communication, structuring and relational analysis.The benefits of music therapy for our bodies and our behavior are numerous, including improvements in cognitive functions (attention, memory), psychomotor functions (agility, mobility, coordination) and social-emotional functions (healthymind website 10/03/2021).

NCT ID: NCT03357185 Completed - Atheromatous Clinical Trials

Prospective Evaluation of Femoral Tripod Eversion Technique

Eversion
Start date: June 1, 2014
Phase:
Study type: Observational

Endarteriectomy is considered as the first line treatment of femoral bifurcation atheromatous lesions. Eversion technique, similar to that used for carotid bifurcation, is safe and possible for the majority of the femoral tripod lesions. The major advantage of the eversion technique is the absence of prosthetic material to be performed. However, its use has been scarcely evaluated in the literature to date. This work aims at evaluating the long term safety and the efficacy of eversion femoral technique. Surgical technique was thoroughly described and participants were followed up for two years by serial clinical and doppler US examination.